NEW YORK (GenomeWeb) – Natera has filed with the US Securities and Exchange Commission for a proposed $100 million common stock offering.

The San Carlos, California-based molecular diagnostics firm filed the automatic shelf registration statement at the close of the market Tuesday. Based on its closing price of $20.28 on Monday, Natera said that it would offer around 4.9 million shares.